IL6 and diabetes mellitus: In fact, elevated levels of inflammatory markers [interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), and C-reactive protein (CRP)] were shown to increase neutrophil apoptosis and impair neutrophil clearance in patients with diabetes [2].